Newcore Gold Ltd. (PCR.V) (CVE:PCR – Get Free Report) Director Barry Johnson Blayne bought 50,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 24th. The shares were acquired at an average price of C$0.31 per share, with a total value of C$15,250.00.
Newcore Gold Ltd. (PCR.V) Price Performance
Shares of CVE:PCR opened at C$0.74 on Thursday. Newcore Gold Ltd. has a 1-year low of C$0.14 and a 1-year high of C$0.86. The company has a market capitalization of C$59.16 million and a P/E ratio of -185.00. The firm’s 50 day simple moving average is C$0.74 and its two-hundred day simple moving average is C$0.74.
About Newcore Gold Ltd. (PCR.V)
See Also
- Five stocks we like better than Newcore Gold Ltd. (PCR.V)
- What is the S&P/TSX Index?
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- What is the Euro STOXX 50 Index?
- 2 Drone Stocks Surging from Increased Media Attention
- Election Stocks: How Elections Affect the Stock Market
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Newcore Gold Ltd. (PCR.V) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Newcore Gold Ltd. (PCR.V) and related companies with MarketBeat.com's FREE daily email newsletter.